PPIDT00246
Drug Information
| Name | Peginesatide |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB08894 |
| Type | biotech |
| Indication | Peginesatide is used for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Solution | Intravenous; Parenteral; Subcutaneous |
1 mg/0.5mL
|
| Solution | Intravenous; Parenteral; Subcutaneous |
10 mg/1mL
|
| Solution | Intravenous; Parenteral; Subcutaneous |
2 mg/0.5mL
|
| Solution | Intravenous; Parenteral; Subcutaneous |
20 mg/2mL
|
| Solution | Intravenous; Parenteral; Subcutaneous |
3 mg/0.5mL
|
| Solution | Intravenous; Parenteral; Subcutaneous |
4 mg/0.5mL
|
| Solution | Intravenous; Parenteral; Subcutaneous |
5 mg/0.5mL
|
| Solution | Intravenous; Parenteral; Subcutaneous |
6 mg/0.5mL
|